Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Brian A. Federici is active.

Publication


Featured researches published by Brian A. Federici.


Molecular Microbiology | 1994

Synergism of mosquitocidal toxicity between CytA and CrylVD proteins using inclusions produced from cloned genes of Bacillus thuringiensis

Dong Wu; Jeffrey J. Johnson; Brian A. Federici

The toxicity to mosquito larvae of the parasporal body produced by Bacillus thuringiensis subsp. israelensis and the PG‐14 isolate of B. thuringiensis subsp. morrisoni is at least 20‐fold greater than any of the four mosquitocidal proteins of which It is composed (CytA, CrylVA, B, and D). This high toxicity is postulated to be due to synergistic interactions among parasporal proteins. However, this remains controversial because values reported for the specific toxicity of individual proteins, especially the CytA protein, vary widely owing to the methods used to purify and assay toxins against larvae. In an attempt to resolve questions of purity, specific toxicity, and synergism, individual genes encoding the CytA and CrylVD toxins were cloned and expressed in acrystalliferous B. thuringiensis subsp. israelensis cells using the shuttle vector pHT3101. CytA and CryIVD inclusions were purified and their toxicity was determined alone and when combined at different ratios using bio‐assays against first instars of Aedes aegypti. The LC50 for the CytA inclusion was 60 ng ml−1, whereas the LC50 for the CryIVD was 85ng ml−1 In comparison, the LC50s for different combinations of CytA and CrylVD inclusions ranged from 12–15 ng ml−1, 4–5 times higher than the toxicity of either protein alone, demonstrating marked synergism between these two proteins. These results suggest that the high toxicity of the wild‐type parasporal bodies of B. thuringiensis subspp. israelensis and morrisoni Is due to synergism among three or four of their major proteins.


The Journal of Experimental Biology | 2003

Recombinant bacteria for mosquito control

Brian A. Federici; Dennis K. Bideshi; Margaret C. Wirth; Jeffrey J. Johnson

SUMMARY Bacterial insecticides have been used for the control of nuisance and vector mosquitoes for more than two decades. Nevertheless, due primarily to their high cost and often only moderate efficacy, these insecticides remain of limited use in tropical countries where mosquito-borne diseases are prevalent. Recently, however, recombinant DNA techniques have been used to improve bacterial insecticide efficacy by markedly increasing the synthesis of mosquitocidal proteins and by enabling new endotoxin combinations from different bacteria to be produced within single strains. These new strains combine mosquitocidal Cry and Cyt proteins of Bacillus thuringiensis with the binary toxin of Bacillus sphaericus, improving efficacy against Culex species by 10-fold and greatly reducing the potential for resistance through the presence of Cyt1A. Moreover, although intensive use of B. sphaericus against Culex populations in the field can result in high levels of resistance, most of this can be suppressed by combining this bacterial species with Cyt1A; the latter enables the binary toxin of this species to enter midgut epithelial cells via the microvillar membrane in the absence of a midgut receptor. The availability of these novel strains and newly discovered mosquitocidal proteins, such as the Mtx toxins of B. sphaericus, offers the potential for constructing a range of recombinant bacterial insecticides for more effective control of the mosquito vectors of filariasis, Dengue fever and malaria.


Applied and Environmental Microbiology | 2005

Cyt1A of Bacillus thuringiensis Delays Evolution of Resistance to Cry11A in the Mosquito Culex quinquefasciatus

Margaret C. Wirth; William E. Walton; Brian A. Federici

ABSTRACT Insecticides based on Bacillus thuringiensis subsp. israelensis have been used for mosquito and blackfly control for more than 20 years, yet no resistance to this bacterium has been reported. Moreover, in contrast to B. thuringiensis subspecies toxic to coleopteran or lepidopteran larvae, only low levels of resistance to B. thuringiensis subsp. israelensis have been obtained in laboratory experiments where mosquito larvae were placed under heavy selection pressure for more than 30 generations. Selection of Culex quinquefasciatus with mutants of B. thuringiensis subsp. israelensis that contained different combinations of its Cry proteins and Cyt1Aa suggested that the latter protein delayed resistance. This hypothesis, however, has not been tested experimentally. Here we report experiments in which separate C. quinquefasciatus populations were selected for 20 generations to recombinant strains of B. thuringiensis that produced either Cyt1Aa, Cry11Aa, or a 1:3 mixture of these strains. At the end of selection, the resistance ratio was 1,237 in the Cry11Aa-selected population and 242 in the Cyt1Aa-selected population. The resistance ratio, however, was only 8 in the population selected with the 1:3 ratio of Cyt1Aa and Cry11Aa strains. When the resistant mosquito strain developed by selection to the Cyt1Aa-Cry11Aa combination was assayed against Cry11Aa after 48 generations, resistance to this protein was 9.3-fold. This indicates that in the presence of Cyt1Aa, resistance to Cry11Aa evolved, but at a much lower rate than when Cyt1Aa was absent. These results indicate that Cyt1Aa is the principal factor responsible for delaying the evolution and expression of resistance to mosquitocidal Cry proteins.


Applied and Environmental Microbiology | 2000

Cyt1A from Bacillus thuringiensis Synergizes Activity of Bacillus sphaericus against Aedes aegypti (Diptera: Culicidae)

Margaret C. Wirth; Brian A. Federici; William E. Walton

ABSTRACT Bacillus sphaericus is a mosquitocidal bacterium recently developed as a commercial larvicide that is used worldwide to control pestiferous and vector mosquitoes. Whereas B. sphaericus is highly active against larvae of Culexand Anopheles mosquitoes, it is virtually nontoxic toAedes aegypti, an important vector species. In the present study, we evaluated the capacity of the cytolytic protein Cyt1A fromBacillus thuringiensis subsp. israelensis to enhance the toxicity of B. sphaericus toward A. aegypti. Various combinations of these two materials were evaluated, and all were highly toxic. A ratio of 10:1 of B. sphaericus to Cyt1A was 3,600-fold more toxic to A. aegypti than B. sphaericus alone. Statistical analysis showed this high activity was due to synergism between the Cyt1A toxin and B. sphaericus. These results suggest that Cyt1A could be useful in expanding the host range of B. sphaericus.


Journal of Invertebrate Pathology | 1986

Continuous cell line from Spodoptera exigua (Lepidoptera: Noctuidae) that supports replication of nuclear polyhedrosis viruses from Spodoptera exigua and Autographa californica

Wendy D. Gelernter; Brian A. Federici

Abstract A continuous cell line, designated UCR-SE-1, has been established from larvae of the beet armyworm, Spodoptera exigua (Lepidoptera: Noctuidae). The cell line was established from minced neonate larvae treated with collagenase, and is grown in a modified TNM-FH medium with an osmotic pressure of 400 mOsm. The cell line consists of a mixture of two cell types, epithelial-like cells and spindle-shaped cells, both of which grow as attached monolayers. The cell line has a population doubling time of 56 hr, and has undergone more than 100 serial passages. Greater than 90% of the spindle-shaped cells support replication of the multiple nucleocapsid nuclear polyhedrosis viruses from Spodoptera exigua and Autographa californica , although the epithelial-like cells support replication of the latter virus only.


Journal of The American Mosquito Control Association | 2007

DEVELOPING RECOMBINANT BACTERIA FOR CONTROL OF MOSQUITO LARVAE

Brian A. Federici; Dennis K. Bideshi; Margaret C. Wirth; Jeffrey J. Johnson; Yuko Sakano; Mujin Tang

ABSTRACT Genetic engineering techniques have been used to significantly improve mosquito larvicides based on the bacteria Bacillus thuringiensis (Bt) subsp. israelensis (Bti) and Bacillus sphaericus (Bs). These new larvicides hold excellent promise for providing better and more cost-effective control of nuisance mosquitoes and vectors of important diseases, including the anopheline vectors of malaria and culicine vectors responsible for filariasis and viral encephalitides. The toxicity of Bti and Bs is due primarily to endotoxin proteins produced during sporulation. After ingestion by larvae, these are activated and destroy the larval stomach, quickly resulting in death. By cloning the genes encoding various endotoxins from Bt and Bs species, and engineering these for high levels of synthesis, we have been able to generate recombinant bacterial strains based on Bti that are more than 10 times as effective as the conventional strains of Bti or Bs that serve as the active ingredients of commercial bacterial larvicides currently used for mosquito control. The best of these recombinants contain all major Bti endotoxins, specifically, Cry4A, Cry4B, Cry11A, and Cyt1A, plus the binary (Bin) endotoxin of Bs, the principal mosquitocidal protein responsible for the activity of this species. The presence of Cyt1A in these recombinants, which synergizes Cry toxicity and delays resistance to these proteins and Bs Bin, should enable long term use of these recombinants with little if any development of resistance. In the field, these new recombinants should be particularly effective larvicides against most important vectors and nuisance species of the genus Culex, the malaria vectors Anopheles gambiae and An. arabiensis, and species of Aedes and Ochlerotatus sensitive to Bs.


Proceedings of the National Academy of Sciences of the United States of America | 2014

Protein crystal structure obtained at 2.9 Å resolution from injecting bacterial cells into an X-ray free-electron laser beam

Michael R. Sawaya; Duilio Cascio; Mari Gingery; José A. Rodriguez; Lukasz Goldschmidt; Jacques-Philippe Colletier; Marc Messerschmidt; Sébastien Boutet; Jason E. Koglin; Garth J. Williams; Aaron S. Brewster; Karol Nass; Johan Hattne; Sabine Botha; R. Bruce Doak; Robert L. Shoeman; Daniel P. DePonte; Brian A. Federici; Nicholas K. Sauter; Ilme Schlichting; David Eisenberg

Significance In vivo microcrystals have been observed in prokaryotic and eukaryotic cells. With rare exception, however, the ∼100,000 biological structures determined by X-ray crystallography to date have required the macromolecule under study to be extracted from the cells that produced it and crystallized in vitro. In vivo crystals present a challenge for structure determination and pose the question of the extent to which in vivo macromolecular structures are similar to those of extracted and recrystallized macromolecules. Here we show that serial femtosecond crystallography enabled by a free-electron laser yields the structure of in vivo crystals, as they exist in a living cell, and in this case the in vivo structure is essentially identical to the structure of extracted and recrystallized protein. It has long been known that toxins produced by Bacillus thuringiensis (Bt) are stored in the bacterial cells in crystalline form. Here we describe the structure determination of the Cry3A toxin found naturally crystallized within Bt cells. When whole Bt cells were streamed into an X-ray free-electron laser beam we found that scattering from other cell components did not obscure diffraction from the crystals. The resolution limits of the best diffraction images collected from cells were the same as from isolated crystals. The integrity of the cells at the moment of diffraction is unclear; however, given the short time (∼5 µs) between exiting the injector to intersecting with the X-ray beam, our result is a 2.9-Å-resolution structure of a crystalline protein as it exists in a living cell. The study suggests that authentic in vivo diffraction studies can produce atomic-level structural information.


Journal of Medical Entomology | 2000

Cyt1A from Bacillus thuringiensis Restores Toxicity of Bacillus sphaericus Against Resistant Culex quinquefasciatus (Diptera: Culicidae)

Margaret C. Wirth; William E. Walton; Brian A. Federici

Abstract The 2362 strain of Bacillus sphaericus, which produces a binary toxin highly active against Culex mosquitoes, has been developed recently as a commercial larvicide. It is being used currently in operational mosquito control programs in several countries including Brazil, France, India, and the United States. Laboratory studies have shown that mosquitoes can develop resistance to B. sphaericus, and low levels of resistance have already been reported in field populations in Brazil, France, and India. To develop tools for resistance management, the Cyt1A protein of Bacillus thuringiensis subsp. israelensis De Barjac was evaluated for its ability to suppress resistance to B. sphaericus in a highly resistant population of Culex quinquefasciatus Say. A combination of B. sphaericus 2362 in a 10:1 ratio with a strain of B. thuringiensis subsp. israelensis that only produces Cyt1A reduced resistance by >30,000-fold. Resistance was suppressed completely when B. sphaericus was combined with purified Cyt1A crystals in a 10:1 ratio. Synergism was observed between the Cyt1A toxin and B. sphaericus against the resistant mosquito population and accounted for the marked reduction in resistance. However, no synergism was observed between the toxins against a nonresistant mosquito population. These results indicate that Cyt1A could be useful for managing resistance to B. sphaericus 2362 in Culex populations, and also provide additional evidence that Cyt1A may synergize toxicity by enhancing the binding to and insertion of toxins into the mosquito microvillar membrane.


Journal of Invertebrate Pathology | 1979

Pathogenesis and midgut histopathology of Bacillus thuringiensis in Simulium vittatum (Diptera: Simuliidae)

Lawrence A. Lacey; Brian A. Federici

Abstract The pathogenesis and midgut histopathology which resulted when larvae of the blackfly, Simulium vittatum , were exposed to Bacillus thuringiensis at various temperatures and periods of exposure were investigated. The onset of mortality was studied at 10°, 15°, 19°, and 24°C. For each 4–5°C increase in temperature above 15°C, the onset of mortality was shortened by 24 hr. Exposures as brief as 15 min to 10 ppm of a whole spore preparation resulted in an average mortality of 29% in late-instar larvae. Mortality increased sharply for exposures up to 3 hr, approaching a maximum of 80%. The gross signs of disease included cessation of feeding and tetany with brachytosis. The tissue most affected was the midgut epithelium in the regions of the gastric caeca and posterior stomach. The formation of cytoplasmic vacuoles followed by cell lysis and/or sloughing were very apparent in moribund larvae. Death resulted without bacteremia.


Transgenic Research | 2009

Setting the record straight: a rebuttal to an erroneous analysis on transgenic insecticidal crops and natural enemies

Anthony M. Shelton; Steven E. Naranjo; Jörg Romeis; Richard L. Hellmich; Jeffrey D. Wolt; Brian A. Federici; Ramon Albajes; Franz Bigler; Elisabeth P.J. Burgess; Galen P. Dively; Angharad M. R. Gatehouse; Louise A. Malone; Richard T. Roush; Mark K. Sears; Frantisek Sehnal

As scientists involved in risk assessment of transgenicinsecticidal plants, we are greatly concerned about thepublication by Lo¨vei et al. (2009) implying thatinsect-protected crops based on the Cry proteins ofBacillus thuringiensis may have substantial negativeimpacts on non-target organisms. We believe thatLo¨vei et al. (2009) use inappropriate and unsoundmethods for risk assessment that have led them toreach conclusions that are in conflict with those ofseveral recent comprehensive reviews and meta-analyses (e.g., O’Callaghan et al. 2005; Romeiset al. 2006; Marvier et al. 2007; Wolfenbarger et al.

Collaboration


Dive into the Brian A. Federici's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yves Bigot

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mir S. Mulla

University of California

View shared research outputs
Top Co-Authors

Avatar

Robert H. Hice

University of California

View shared research outputs
Top Co-Authors

Avatar

Corinne Cruaud

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yeping Tan

University of California

View shared research outputs
Researchain Logo
Decentralizing Knowledge